Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > HUMA Humacyte > Detailed Quotes

HUMA Humacyte

Watchlist
3.230
+0.150+4.87%
Close  02/03 16:00 ET
3.240
+0.010+0.31%
Post Mkt Price 02/03 16:30 ET
High
3.320
Open
3.040
Turnover
607.89K
Low
3.010
Pre Close
3.080
Volume
189.06K
Market Cap
333.07M
P/E(TTM)
9.70
52wk High
8.040
Shares
103.12M
P/E(Static)
Loss
52wk Low
1.960
Float Cap
172.32M
Bid/Ask %
66.67%
Historical High
17.450
Shs Float
53.35M
Volume Ratio
0.62
Historical Low
0.000
Dividend TTM
--
Div Yield TTM
--
P/B
2.81
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.35%
Amplitude
10.07%
Avg Price
3.215
Lot Size
1
Float Cap
172.32M
Bid/Ask %
66.67%
Historical High
17.450
Shs Float
53.35M
Volume Ratio
0.62
Historical Low
0.000
Dividend TTM
--
P/B
2.81
Dividend LFY
--
Turnover Ratio
0.35%
Amplitude
10.07%
Avg Price
3.215
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Humacyte, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason and Juliana L. Blum in October 13, 2004 and is headquartered in Durham, NC.
CEO: Ms. Laura E. Niklason
Market: NASDAQ
Listing Date: 12/01/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist